Progression-Free Survival and Overall Survival of CDK 4/6 Inhibitors Plus Endocrine Therapy in Metastatic Breast Cancer: A Systematic Review and Meta-Analysis

por Piezzo, Michela, Chiodini, Paolo, Riemma, Maria, Cocco, Stefania, Caputo, Roberta, Cianniello, Daniela, Di Gioia, Germira, Di Lauro, Vincenzo, Rella, Francesca Di, Fusco, Giuseppina, Iodice, Giovanni, Nuzzo, Francesco, Pacilio, Carmen, Pensabene, Matilde, Laurentiis, Michelino De
Publicado en Int J Mol Sci (2020)

Eribulin for metastatic breast cancer (MBC) treatment: a retrospective, multicenter study based in Campania, south Italy (Eri-001 trial)

por Orditura, Michele, Gravina, Adriano, Riccardi, Ferdinando, Diana, Anna, Mocerino, Carmela, Leopaldi, Luigi, Fabozzi, Alessio, Giordano, Guido, Nettuno, Raffaele, Incoronato, Pasquale, Barzelloni, Maria Luisa, Caputo, Roberta, Pisano, Agata, Grimaldi, Giuseppe, Genua, Geppino, Montesarchio, Vincenzo, Barbato, Enrico, Iodice, Giovanni, Lieto, Eva, Procaccini, Eugenio, Mabilia, Roberto, Febbraro, Antonio, Laurentiis, Michelino De, Ciardiello, Fortunato
Publicado en ESMO Open (2017)